Best Mid Cap Funds
Tomorrow's large caps. Higher growth, higher swings — reward the patient.
Data updated · 34 direct-growth funds ranked by a transparent 0–100 Smart Score
| ⚖ VS | Fund | Score ↓ | Verdict | 1Y | 3Y | 5Y | Sharpe | Sortino | Std Dev | Alpha | Beta | VR★ | P/E | Expense | AUM | Age |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Invesco India Midcap Invesco | 79 | Strong Buy | 8.0% | 23.4% | 19.7% | 0.99 | 1.39 | 19.6 | 6.0 | 1.01 | 5★ | 50.5 | 0.76% | ₹15.9k Cr | 13.7y | |
| WhiteOak Capital Mid Cap WhiteOak | 78 | Strong Buy | 13.0% | 22.0% | — | 1.03 | 1.34 | 16.9 | 5.7 | 0.89 | 5★ | 31.9 | 0.97% | ₹7.5k Cr | 4.0y | |
| HSBC Midcap HSBC | 76 | Buy | 18.6% | 24.2% | 19.0% | 1.02 | 1.28 | 20.1 | 6.9 | 1.02 | — | 35.3 | 1.19% | ₹17.2k Cr | 13.7y | |
| Helios Mid Cap Helios | 74 | Buy | 13.3% | — | — | 1.26 | 1.83 | 16.1 | 8.0 | 0.93 | — | 47.4 | 1.00% | ₹2.2k Cr | 1.5y | |
| Edelweiss Midcap Edelweiss | 72 | Buy | 6.5% | 20.9% | 18.5% | 0.96 | 0.45 | 17.7 | 4.5 | 0.94 | 5★ | 31.8 | 0.72% | ₹19.9k Cr | 13.7y | |
| HDFC Mid Cap HDFC | 70 | Buy | 6.0% | 17.2% | 18.9% | 0.72 | 0.97 | 15.0 | 1.6 | 0.85 | 4★ | 29.3 | 0.74% | ₹1.08L Cr | 13.7y | |
| ICICI Pru Mid Cap ICICI Pru | 69 | Buy | 13.5% | 21.5% | 17.7% | 0.97 | 1.15 | 18.6 | 4.8 | 0.99 | 4★ | 36.8 | 1.11% | ₹8.4k Cr | 13.7y | |
| Motilal Oswal Midcap Motilal Oswal | 66 | Buy | -2.0% | 18.8% | 21.2% | 0.77 | 1.13 | 20.6 | 3.3 | 0.94 | 4★ | 33.8 | 0.93% | ₹42.9k Cr | 12.6y | |
| Nippon India Gr Mid Cap Nippon India | 66 | Buy | 6.4% | 18.1% | 17.9% | 0.84 | 0.95 | 17.8 | 2.3 | 0.95 | 4★ | 29.3 | 0.78% | ₹52.3k Cr | 13.7y | |
| Baroda BNP Paribas Mid Cap Baroda BNP Paribas | 65 | Buy | 10.3% | 17.0% | 20.5% | 0.69 | 0.93 | 15.2 | 1.3 | 0.86 | — | 30.2 | 0.76% | ₹2.7k Cr | 13.7y | |
| Mahindra Manulife Mid Cap Mahindra Manulife | 64 | Buy | 9.0% | 17.9% | 18.0% | 0.86 | 0.91 | 17.2 | 2.5 | 0.93 | 4★ | 35.5 | 0.75% | ₹5.4k Cr | 8.7y | |
| ITI Mid Cap ITI | 63 | Buy | 10.3% | 20.1% | 16.7% | 0.89 | 1.01 | 18.9 | 3.4 | 1.01 | 3★ | 33.0 | 0.94% | ₹1.5k Cr | 5.5y | |
| Sundaram Midcap Sundaram | 58 | Hold | 5.3% | 18.1% | 16.7% | 0.87 | 0.73 | 17.2 | 2.8 | 0.92 | 4★ | 37.8 | 1.05% | ₹14.9k Cr | 13.7y | |
| JM Mid Cap JM | 57 | Hold | 9.3% | 19.4% | — | 0.81 | 0.98 | 18.9 | 2.3 | 0.98 | 4★ | 37.9 | 0.97% | ₹1.4k Cr | 3.8y | |
| Kotak Midcap Kotak | 56 | Hold | 4.6% | 17.7% | 16.6% | 0.79 | -0.19 | 17.8 | 1.9 | 0.92 | 4★ | 30.4 | 0.51% | ₹71.3k Cr | 13.7y | |
| The Wealth Company Mid Cap The Wealth Company | 56 | Hold | — | — | — | — | — | — | — | — | — | 33.8 | 0.47% | ₹171 Cr | 0.1y | |
| Bandhan Midcap Bandhan | 52 | Hold | 9.1% | 18.7% | — | 0.77 | -0.40 | 18.6 | 1.8 | 0.95 | 4★ | 48.5 | 0.75% | ₹2.6k Cr | 4.1y | |
| Axis Midcap Axis | 52 | Hold | 6.2% | 16.6% | 13.1% | 0.68 | 0.94 | 14.8 | 0.5 | 0.84 | 4★ | 33.5 | 0.82% | ₹35.2k Cr | 13.7y | |
| Canara Robeco Mid Cap Canara Robeco | 51 | Hold | 4.6% | 17.2% | — | 0.78 | 0.91 | 17.2 | 1.4 | 0.90 | 4★ | 40.7 | 0.91% | ₹5.2k Cr | 3.8y | |
| Mirae Asset Midcap Mirae Asset | 48 | Hold | 8.1% | 15.9% | 15.5% | 0.59 | 0.79 | 15.9 | -0.4 | 0.91 | 3★ | 31.4 | 0.95% | ₹20.9k Cr | 7.2y | |
| Union Midcap Union | 44 | Avoid | 8.5% | 17.1% | 15.4% | 0.63 | 0.84 | 16.9 | 0.2 | 0.96 | 3★ | — | 1.13% | ₹2.0k Cr | 6.5y | |
| Tata Mid Cap Tata | 42 | Avoid | 6.0% | 15.4% | 15.0% | 0.57 | 0.76 | 15.5 | -0.6 | 0.88 | 4★ | 37.2 | 0.87% | ₹6.2k Cr | 13.7y | |
| FranklIn India Mid Cap Franklin | 40 | Avoid | 1.1% | 15.6% | 13.7% | 0.59 | 0.80 | 15.5 | -0.4 | 0.88 | 3★ | 35.1 | 1.12% | ₹13.1k Cr | 13.7y | |
| ABSL Midcap Gr Dir Aditya Birla Sun Life | 35 | Avoid | 6.3% | 14.9% | 14.0% | 0.54 | 0.73 | 15.6 | -1.1 | 0.88 | — | — | 1.24% | ₹7.0k Cr | 13.7y | |
| DSP Midcap DSP | 33 | Avoid | 3.3% | 14.2% | 11.6% | 0.49 | 0.67 | 15.7 | -1.9 | 0.89 | 3★ | 22.4 | 0.81% | ₹21.0k Cr | 13.7y | |
| LIC MF Mid Cap LIC | 31 | Avoid | 5.1% | 16.2% | 12.9% | 0.58 | 0.80 | 16.7 | -0.4 | 0.94 | 4★ | 41.0 | 1.78% | ₹392 Cr | 9.6y | |
| SBI Midcap SBI | 31 | Avoid | 3.2% | 10.5% | 13.6% | 0.30 | 0.40 | 13.4 | -4.3 | 0.74 | 2★ | 36.1 | 1.03% | ₹24.5k Cr | 13.7y | |
| PGIM India Midcap PGIM India | 28 | Avoid | -0.5% | 11.4% | 10.8% | 0.33 | 0.45 | 15.2 | -4.2 | 0.85 | 2★ | 29.2 | 0.76% | ₹11.2k Cr | 12.8y | |
| Quant Midcap Gr Quant | 27 | Avoid | 3.6% | 10.9% | 15.9% | 0.26 | 0.35 | 17.1 | -5.3 | 0.91 | 4★ | 31.9 | 1.18% | ₹8.1k Cr | 13.7y | |
| Bank Of India Mid Cap Bank of India | 23 | Avoid | 5.9% | 13.3% | 11.8% | 0.44 | 0.59 | 15.6 | -2.4 | 0.86 | — | 30.5 | 1.37% | ₹767 Cr | 1.1y | |
| UTI Midcap Gr Dir UTI | 20 | Avoid | 2.9% | 11.8% | 11.8% | -0.13 | -0.18 | 17.2 | -2.0 | 1.00 | 3★ | 33.0 | 1.15% | ₹12.8k Cr | 13.7y | |
| Taurus Mid Cap Taurus | 10 | Avoid | 3.6% | 9.8% | 12.2% | 0.18 | 0.24 | 18.3 | -7.6 | 1.00 | — | — | 2.29% | ₹140 Cr | 13.7y | |
| TrustMF Mid Cap Trust | 9 | Avoid | — | — | — | — | — | — | — | — | — | 45.6 | 1.99% | ₹588 Cr | 0.6y | |
| Samco Mid Cap Samco | 6 | Avoid | — | — | — | — | — | — | — | — | — | 16.6 | 1.74% | ₹81 Cr | 0.7y |
Mid Cap funds — quick answers
›Which is the best Mid Cap mutual fund right now?
Invesco India Midcap currently ranks #1 of 34 Mid Cap funds with a FundLens Smart Score of 79/100 (Strong Buy). It returned 23.4% over 3 years and 19.7% over 5 years at a 0.76% expense ratio (direct plan). Rankings are recomputed from data updated 20 Sept 2026.
›Which Mid Cap fund has the best risk-adjusted returns?
Helios Mid Cap leads the category on the Sortino ratio at 1.83 (Sharpe 1.26) — meaning it has delivered the most return per unit of downside risk among Mid Cap funds.
›Which Mid Cap fund has the lowest expense ratio?
The Wealth Company Mid Cap charges 0.47% a year (direct plan) — the lowest in the category. Lower fees compound in your favour over long holding periods.
›Which is the smallest Mid Cap fund by AUM?
Samco Mid Cap manages ₹81 Cr, the smallest in the category. Smaller funds can be nimbler, but check track record and costs before treating size alone as an edge.
›How long should I stay invested in a Mid Cap fund?
Mid Cap funds carry very high risk, so a horizon of 7+ years is generally sensible. Tomorrow's large caps. Higher growth, higher swings — reward the patient. This is research, not investment advice.
Visitors also asked
Want these answers conversationally? Ask FundLens · New to the ratios? Sharpe vs Sortino, explained